Search
Serabelisib
go.drugbank.com/drugs/DB14935InvestigationalSerabelisib is under investigation in clinical trial NCT02625259 (A Study to Evaluate the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics … of TAK-117 (MLN1117) in Healthy Participants).
MM3122
go.drugbank.com/drugs/DB16737ExperimentalCategories: Experimental Unapproved Treatments for COVID-19Fenpiverinium
go.drugbank.com/drugs/DB13759InvestigationalCategories: Drugs for Functional Gastrointestinal DisordersVelsecorat
go.drugbank.com/drugs/DB16347InvestigationalVelsecorat is under investigation in clinical trial NCT02479412 (A Multiple Dosing (14 Days) Study to Assess Efficacy and Safety of Three Dose Levels of AZD7594, Given Once Daily by Inhalation, in Patients … With Mild to Moderate Asthma).
Zebularine
go.drugbank.com/drugs/DB03068ExperimentalAlso shown to inhibit DNA methylation and tumor growth both in vitro and in vivo. … It acts as a transition state analog inhibitor of cytidine deaminase by binding to the active site as covalent hydrates.
Veverimer
go.drugbank.com/drugs/DB18977InvestigationalVeverimer is under investigation in clinical trial NCT03390842 (Long-term Safety Extension to Study TRCA-301).
Synonyms: N1,n3-bis(prop-2-en-1-yl)propan-1,3-diamine copolymer with 1,2-dichloroethane and prop-2-en-1-amine, 1,3-propanediamine, n1,n3-di-2-propen-1-yl-, polymer with 1,2-dichloroethane and 2-propen-1-amineClorindione
go.drugbank.com/drugs/DB13275ExperimentalClorindione is a vitamin K antagonist, which may be useful to decrease prothrombin levels in humans.
Categories: Vitamin K AntagonistsHonokiol
go.drugbank.com/drugs/DB19283InvestigationalHonokiol is under investigation in clinical trial NCT00966953 (Development of Clinical Method to Determination Triclosan Retention in Plaque Following Brushing.).
Lomedeucitinib
go.drugbank.com/drugs/DB21649InvestigationalLomedeucitinib is under investigation in clinical trial NCT05730725 (A Study to Evaluate Effectiveness and Safety of BMS-986322 in Participants With Moderate-to-Severe Psoriasis). … Lomedeucitinib is a small molecule drug. The usage of the INN stem '-citinib' in the name indicates that Lomedeucitinib is a Janus kinase inhibitor.
Ginisortamab
go.drugbank.com/drugs/DB18863InvestigationalGinisortamab is under investigation in clinical trial NCT04393298 (A Study to Assess the Safety, Pharmacokinetics and Anti Tumor Activity of UCB6114 Administered Intravenously to Participants With Advanced